Tan KCB - Search Results

1

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes.

Tan KCB, Chow WS, Tso AWK, Xu A, Tse HF, Hoo RLC, Betteridge DJ, Lam KSL. Tan KCB, et al. Diabetologia. 2007 Sep;50(9):1819-1825. doi: 10.1007/s00125-007-0759-0. Epub 2007 Jul 18. Diabetologia. 2007. PMID: 17639302 Clinical Trial.

2

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.

Tan KC, Chow WS, Tam SC, Ai VH, Lam CH, Lam KS. Tan KC, et al. J Clin Endocrinol Metab. 2002 Feb;87(2):563-8. doi: 10.1210/jcem.87.2.8249. J Clin Endocrinol Metab. 2002. PMID: 11836286 Clinical Trial.

3

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.

Tan KC, Chow WS, Ai VH, Lam KS. Tan KC, et al. Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6. doi: 10.1002/dmrr.255. Diabetes Metab Res Rev. 2002. PMID: 11921421 Free article. Clinical Trial.

4

Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.

Tan KC, O K, Chow WS, Ai VH, Siow YL, Lam KS. Tan KC, et al. Eur J Clin Invest. 2002 May;32(5):328-34. doi: 10.1046/j.1365-2362.2002.00990.x. Eur J Clin Invest. 2002. PMID: 12027872

5

Advanced glycation end products and endothelial dysfunction in type 2 diabetes.

Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Tan KC, et al. Diabetes Care. 2002 Jun;25(6):1055-9. doi: 10.2337/diacare.25.6.1055. Diabetes Care. 2002. PMID: 12032114

6

Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria.

Tan K, Chow WS, Wong Y, Shiu S, Tam S. Tan K, et al. Diabetes Care. 2002 Jul;25(7):1254-5. doi: 10.2337/diacare.25.7.1254. Diabetes Care. 2002. PMID: 12087039 Clinical Trial. No abstract available.

7

Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.

Tan KC, Tso AW, Tam SC, Pang RW, Lam KS. Tan KC, et al. Diabet Med. 2002 Nov;19(11):944-8. doi: 10.1046/j.1464-5491.2002.00823.x. Diabet Med. 2002. PMID: 12421432 Clinical Trial.

8

Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese.

Tso AW, Rong R, Lo CY, Tan KC, Tiu SC, Wat NM, Xu JY, Villablanca A, Larsson C, Teh BT, Lam KS. Tso AW, et al. Clin Endocrinol (Oxf). 2003 Jul;59(1):129-35. doi: 10.1046/j.1365-2265.2003.01812.x. Clin Endocrinol (Oxf). 2003. PMID: 12807514

9

Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism and type 2 diabetes mellitus on LDL subfractions.

Chen SP, Tan KC, Lam KS. Chen SP, et al. Atherosclerosis. 2003 Apr;167(2):287-92. doi: 10.1016/s0021-9150(03)00004-2. Atherosclerosis. 2003. PMID: 12818411 Free article.

10

C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance.

Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS. Tan KC, et al. Diabetes Care. 2003 Aug;26(8):2323-8. doi: 10.2337/diacare.26.8.2323. Diabetes Care. 2003. PMID: 12882856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters